News
- November 8, 2007
-
Amicus Therapeutics and Shire plc enter into $440 million ex-US Licensing Agreement to Develop and Commercialize Amigal™, Plicera™ and AT2220
-
November 7, 2007
-
Tengion - The Gray Sheet: Paving a Path to a Regenerative Medicine Industry.
- November 1, 2007
-
Tranzyme Pharma Closes New $20 Million Financing
- November 1, 2007
-
Discovery Labs Submits Response to FDA Approvable Letter for Surfaxin® for RDS in Premature Infants
-
October 30, 2007
-
Health Day: Virus Shows Some Cancer-Killing Abilities
- October 24, 2007
-
Tranzyme Pharma's Motilin Antagonist TZP-201 Shows Potential for Preventing and Treating Chemotherapy-Induced Diarrhea (CID)
- October 15, 2007
-
Tengion Closes $33 Million in Series C Funding
- October 9, 2007
-
Optherion, Inc. Completes $37 Million Start Up Financing
- October 1, 2007
-
Surfaxin® Process Validation Batches Achieve Stability Milestone to Enable Filing of Response to FDA Approvable Letter
- August 15, 2007
-
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur®, a Novel Extended-Release Opioid Analgesic for Post Operative Pain
-
June 7, 2007
-
Pittsburgh Tribune Review: Medmark Co-Founder Shines
- June 4, 2007
-
Celator Pharmaceuticals® Study Shows Anti-Tumor Activity in Cancer
Patients Treated with Therapy Based on Ratiometric Dosing
- May 31, 2007
-
Amicus Therapeutics Announces Pricing of Initial Public Offering of 5,000,000 Shares of Common Stock
- May 24, 2007
-
Biolex Therapeutics Raises $30 Million to Advance its Hepatitis C Drug Candidate and Other Pipeline Programs
- May 21, 2007
-
NeuroStar TMS Therapy Improved Quality of Life in Patients with Major Depression in Clinical Trials
- March 27, 2007
-
Regado Biosciences Completes $23 Million Series C Financing
- March 21, 2007
-
Amicus Therapeutics Presents Positive Results from Phase 1 Clinical Studies of Plicera™ for Gaucher Disease
- March 19, 2007
-
Amicus Therapeutics Presents Data from Preclinical and Phase 1 Studies of Amigal™ for Fabry Disease.
- February 1, 2007
-
Pfizer to Acquire Biorexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline.